IVIg treatment reduces catalytic antibody titers of renal transplanted patients.

Mahendra, Ankit; Peyron, Ivan; Dollinger, Cécile; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Padiolleau-Lefevre, Séverine; Friboulet, Alain; Boquet, Didier; Legendre, Christophe; Kaveri, Srinivas V; Thaunat, Olivier; Lacroix-Desmazes, Sébastien

Mahendra, Ankit; Peyron, Ivan; Dollinger, Cécile; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Padiolleau-Lefevre, Séverine; Friboulet, Alain; Boquet, Didier; Legendre, Christophe; Kaveri, Srinivas V; Thaunat, Olivier; Lacroix-Desmazes, Sébastien.

Affiliation

Mahendra A; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Unité Mixte de Recherche S 872, Paris, France.

PLoS One ; 8(8): e70731, 2013.

Article in En | MEDLINE | ID: mdl-23967092

Subject(s)

Antibodies, Catalytic/metabolism; Immunoglobulins, Intravenous; Kidney Transplantation; Adult; Aged; Aged, 80 and over; Antibodies, Catalytic/blood; Autoantibodies/blood; Autoantibodies/immunology; Female; Graft Rejection/immunology; Histocompatibility Antigens/immunology; Humans; Hydrolysis; Immunoglobulin G/blood; Immunoglobulin G/metabolism; Immunoglobulins, Intravenous/administration & dosage; Male; Middle Aged; Prognosis; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Kidney Transplantation / Immunoglobulins, Intravenous / Antibodies, Catalytic Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google